Revenue - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Portage Biotech Inc
Revenue Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Revenue
$82.6m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
28%
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$207.1m
CAGR 3-Years
53%
CAGR 5-Years
238%
CAGR 10-Years
72%
Covalon Technologies Ltd
XTSX:COV
Revenue
CA$29.2m
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
12%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.9m
CAGR 3-Years
-6%
CAGR 5-Years
-14%
CAGR 10-Years
-4%

See Also

What is Portage Biotech Inc's Revenue?
Revenue
0 USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Revenue amounts to 0 USD.

Back to Top